Custom Protocol Design Based on your consultation, our medical team designs a personalized KPV protocol including dosage, administration method (subcutaneous injection, oral capsule, or both), cycle length, and any complementary peptides or therapies
To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch Assembled and Distributed by IT3 Medical, LLC 4447 N Central Expy
Call us today at (385) 240-1000 Follow us on Instagram: @thereclinic Visit us online: www.thereclinic.com
A preclinical safety evaluation published in ScienceDirect confirmed that BPC-157 showed no test-related toxicity in single-dose and repeated-dose studies across mice, rats, rabbits, and dogs, with no genetic or embryo-fetal toxicity detected